Scholars@Duke
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma.

Publication ,  Journal Article
Vlahovic, G; Fecci, PE; Reardon, D; Sampson, JH
Published in: Neuro Oncol
August 2015
Published version (DOI) Link to item

Duke Scholars

Gordana Vlahovic
Author Gordana Vlahovic Medicine, Medical Oncology
Peter Edward Fecci
Author Peter Edward Fecci Neurosurgery
John Howard Sampson
Author John Howard Sampson Neurosurgery
Altmetric Attention Stats
Dimensions Citation Stats

Published In

Neuro Oncol

DOI

10.1093/neuonc/nov071

EISSN

1523-5866

Publication Date

August 2015

Volume

17

Issue

8

Start / End Page

1043 / 1045

Location

England

Related Subject Headings

  • Oncology & Carcinogenesis
  • Lymphocytes, Tumor-Infiltrating
  • Humans
  • Glioblastoma
  • Brain Neoplasms
  • B7-H1 Antigen
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Vlahovic, G., Fecci, P. E., Reardon, D., & Sampson, J. H. (2015). Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma. Neuro Oncol, 17(8), 1043–1045. https://doi.org/10.1093/neuonc/nov071
Vlahovic, Gordana, Peter E. Fecci, David Reardon, and John H. Sampson. “Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma.” Neuro Oncol 17, no. 8 (August 2015): 1043–45. https://doi.org/10.1093/neuonc/nov071.
Vlahovic G, Fecci PE, Reardon D, Sampson JH. Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma. Neuro Oncol. 2015 Aug;17(8):1043–5.
Vlahovic, Gordana, et al. “Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma.” Neuro Oncol, vol. 17, no. 8, Aug. 2015, pp. 1043–45. Pubmed, doi:10.1093/neuonc/nov071.
Vlahovic G, Fecci PE, Reardon D, Sampson JH. Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma. Neuro Oncol. 2015 Aug;17(8):1043–1045.
Journal cover image

Published In

Neuro Oncol

DOI

10.1093/neuonc/nov071

EISSN

1523-5866

Publication Date

August 2015

Volume

17

Issue

8

Start / End Page

1043 / 1045

Location

England

Related Subject Headings

  • Oncology & Carcinogenesis
  • Lymphocytes, Tumor-Infiltrating
  • Humans
  • Glioblastoma
  • Brain Neoplasms
  • B7-H1 Antigen
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences